undefined icon

ERAS - Keuangan

Pre-MarketPre-Market

Erasca, Inc.

$--
0
--
0
Belum ada data.
iconPerforma Harga
Harga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)-
Harga Terendah (52 Minggu)-
Latar Belakang Perusahaan
Erasca, Inc. is a precision oncology company developing targeted therapies for patients with cancer.

Income Statement

20252024202320222021

Total Revenue

-----

Gross Profit

(3.11M)(3.81M)(3.73M)(2.64M)(829,000)

Operating Income

(131.41M)(179.59M)(141.53M)(247.45M)(124.88M)

Net Income

(124.55M)(161.65M)(125.04M)(242.81M)(122.76M)

Net Margin %

-----

Saham Terkait